Geniposide treatment suppresses proliferation, induces apoptosis, and regulates the HCP5/miR-27b-3p/MET axis in DLBCL cells, which may provide potential therapeutic strategies. This evidence concerns the gene HCP5 and diffuse large B-cell lymphoma.